SCIENTIFIC HUB

Follow the evidence.

3.270 articles found

Open access

The future of biomarkers for vascular contributions to cognitive impairment and dementia (VCID): proceedings of the 2025 annual workshop of the Albert research institute for white matter and cognition.

Lennon MJ, Karvelas N, Ganesh A, Whitehead S, Sorond FA, Durán Laforet V, Head E, Arfanakis K, Kolachalama VB, Liu X, Lu H, Ramirez J, Walker K, Weekman E, Wellington CL, Winston C, Barone FC, Corriveau RA.

Geroscience · 2025-06-21

DOI: 10.1007/s11357-025-01746-yPMID: 40542975

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

A Comprehensive Study of Circulating Blood Linear RNA nominates CD55 and DLD as novel causal genes and early-stage biomarkers for Parkinson’s Disease

Beric A, Sahin S, Sanchez S, Yang Z, Kumar R, Alfradique-Dunham I, Sanford J, Western D, Phillips B, Budde JP, Perrin RJ, Kotzbauer PT, Perlmutter JS, Norris SA, Cruchaga C, Ibanez L.

· 2025-06-20

DOI: 10.1101/2025.06.20.25329948

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Saliva as a potential diagnostic medium: DNA methylation biomarkers for disorders beyond the oral cavity.

Hernangomez-Laderas A, Cilleros-Portet A, Marí S, González-García BP, Arregi A, Jimeno-Romero A, Irizar A, García-Santisteban I, Lesseur C, Fernandez-Jimenez N, Bilbao JR.

NPJ Genom Med · 2025-06-20

DOI: 10.1038/s41525-025-00509-0PMID: 40541940

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Genetic mechanisms, brain structures, and peripheral biomarkers mediate the relationship between physical frailty and neuropsychiatric disorders.

Gao PY, Fu Y, He XY, Zhang DD, Chi HC, Huang YM, Wang ZB, Zhang W, Ou YN, Ge YJ, You J, Ma LZ, Qiang YX, Zhao B, Yu HH, Feng J, Tan L, Cheng W, Zhang YR, Yu JT.

J Adv Res · 2025-06-19

DOI: 10.1016/j.jare.2025.06.046PMID: 40543840

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Exploratory digital outcome measures of motor sign progression in Parkinson's disease patients treated with prasinezumab.

Taylor KI, Lipsmeier F, Scelsi MA, Volkova-Volkmar E, Rukina D, Popp W, Lambrecht S, Anzures-Cabrera J, Summers D, Abt M, Monnet A, Kilchenmann T, Schjodt-Eriksen J, Essioux L, Kustermann T, Zago W, Svoboda H, Nikolcheva T, Postuma RB, Pagano G, Lindemann M, PASADENA Investigators, Prasinezumab Study Group.

NPJ Digit Med · 2025-06-16

DOI: 10.1038/s41746-025-01572-8PMID: 40523921

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

Multiplex Proteomics of Lewy Body Dementia Reveals Cerebrospinal Fluid Biomarkers of Clinical and Neuropathological Heterogeneity

Higginbotham L, Rathore S, Shantaraman A, Guo Q, Fox EJ, Bagchi P, Wu F, Denkinger MN, Hanley D, Ashton NJ, the Alzheimer’s Disease Neuroimaging Initiative, Johnson EC, Lah JJ, Levey AI, Seyfried NT.

· 2025-06-13

DOI: 10.1101/2025.06.10.658994

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.